Will Kalvista Pharmaceuticals Inc (KALV) Beat the Rest of the Stocks in the Healthcare Sector?

A rating of 94 puts Kalvista Pharmaceuticals Inc (KALV) near the top of the Healthcare sector according to InvestorsObserver. Kalvista Pharmaceuticals Inc's score of 94 means that it ranks higher than 94% of stocks in the sector. In addition, its overall score of 83 ranks it higher than 83% of all stocks.

KALV has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on KALV!

See Full KALV Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 83 means the stock is more attractive than 83 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Kalvista Pharmaceuticals Inc Stock Today?

Kalvista Pharmaceuticals Inc (KALV) stock has fallen -4.66% while the S&P 500 has risen 0.85% as of 1:38 PM on Tuesday, Mar 12. KALV has fallen -$0.61 from the previous closing price of $13.10 on volume of 178,055 shares. Over the past year the S&P 500 has gained 33.87% while KALV has risen 66.76%. KALV lost -$3.06 per share the over the last 12 months. Click Here to get the full Stock Report for Kalvista Pharmaceuticals Inc stock.